| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |